 |
 |
 |
|
|
|
 |
 |
 |
| |
Archive for the ‘State False Claims Acts’ Category
Tuesday, August 31st, 2010
The Massachusetts Attorney General settled claims of off label marketing with medical device maker, Stryker Biotech. The state claimed that Stryker violated state consumer protection laws by falsifying documents from Massachusetts hospitals’ Institutional Review Boards in order to obtain get approval for the use of its bone growth products. Thus, Stryker was alleged to have marketed products that the government had yet to approve. “Off label” marketing describes the illegal practice of marketing a product for a use that was not approved. Such “off-label” marketing is misleading to health care providers about the appropriate use of approved products. Stryker Biotech agreed to pay the state $1.35 million to settle the claims.
For more information see: http://www.bizjournals.com/boston/stories/2010/08/23/daily27.html?ana=e_du_pub
Posted in Healthcare, State False Claims Acts | No Comments »
Friday, August 20th, 2010
On August 16, 2010, New York Governor David A. Paterson signed into law legislation strengthening New York’s False Claims Act. The New York False Claims Act allows individuals to bring civil actions (“qui tam”) on behalf of the state to recover fraudulent payments and overpayments made to third-party suppliers of goods and services. The state may choose to intervene in such an action or allow the action to proceed as a private suit. The new legislation permits “qui tam” plaintiffs to bring actions for tax fraud, but only when the net income or sales of the defendant total $1 million or more and the damages pleaded in the action exceed $350,000. Moreover, the legislation strengthens the protections for whistle-blowers who recover information concerning the misuse of government funds. The value of these recoveries to New York State is estimated at over $20 million each year.
The President of the New York State Bar Association, Stephen P. Younger, commended Governor Paterson by stating, “This legislation strengthens the existing New York False Claims Act by enhancing the state’s ability to obtain financial recovery for losses suffered due to fraud perpetrated by contractors and others against the government.” President Younger continued, “The state bar and its Commercial and Federal Litigation section have long been supporters of the New York False Claims Act. I want to commend the Governor and the State Legislature for making these much-needed enhancements to further protect the interests of all New Yorkers.”
For more information see: http://readme.readmedia.com/State-Bar-Commends-Governor-Paterson-for-Signing-Legislation-to-Strengthen-New-Yorks-False-Claims-Act/1695467
Posted in State False Claims Acts | No Comments »
Wednesday, July 28th, 2010
Universal Health Services, one of the nation’s largest healthcare management companies, is embroiled in a suit pending in Sacramento County, California related to allegations brought by private whistleblowers under California’s False Claims Act that the company bilked the state of public money through special education schools the company owns. According to the allegations, brought by former employees and a student, UHS-owned schools in California, including UHS Keystone-Sacramento and a former Elmira campus in Solano, allegedly falsified records, charged the state for absent students, understaffed classrooms, and employed uncertified teachers while receiving public education funding. The plaintiffs’ attorney was quoted as saying: “They were warehousing the kids and not providing sufficient education. They make a lot of money by charging all this money for educational services. I think it’s a nationwide scam.”
Read more: http://www.sacbee.com/2010/07/24/2911751/sacramento-special-education-school.html#ixzz0uuWhOz5W
For more information, see: http://www.sacbee.com/2010/07/24/2911751/sacramento-special-education-school.html#ixzz0unSAhlWp
Posted in State False Claims Acts | No Comments »
Monday, July 26th, 2010
Maryland Lieutenant Governer, Anthony Brown, presently campaigning with Martin O’Malley for re-election this fall, announced that the state’s health department has uncovered $26 million in fraud and waste within the state’s Medicaid program for fiscal year 2010. The Maryland Department of Health and Mental Hygiene has recovered fraudulently obtained funds of approximately $100 million since FY 2006, and expects the number to increase beginning in October, when the Maryland False Health Claims Act of 2010, for which Brown lobbied, goes into effect. The State Health Department believes that total recoveries for the year, taking into account the new Act, could reach $46.5 million, a 75% increase over the prior year.
For more information, see http://weblogs.baltimoresun.com/news/local/politics/2010/07/lt_governor_anthony_brown_tout.html
and http://www.dhmh.state.md.us/pressreleases/2010/ltgov072210.html
Posted in State False Claims Acts | No Comments »
Thursday, July 22nd, 2010
On Wednesday, July 21, 2010, President Barack Obama signed into law the Dodd-Frank Wall Street Reform and Consumer Protection Act. The law provides sweeping new consumer protections in the form of ending certain predatory consumer lending and providing stricter regulatory oversight of consumer credit mortgages. Further, the new law seeks to halt “over the counter” derivatives and limit banks’ trading for profit.
Another more obscure provision of the bill is a whistleblower provision that provides greater cash incentives to whistleblowers who provide the Securities and Exchange Commission with information that leads to the successful prosecution of securities laws violations. Specifically, the provision authorizes a minimum award by the SEC of 10% and a maximum of 30% of the recovery of any amount over $1,000,000 that is secured as a result of information provided by the whistleblower, even if some of that information is already widely known.
Some believe that this new provision will have significant impact in the context of the Foreign Corrupt Practices Act, which prohibits companies from engaging in certain practices, including bribery, in foreign countries. Recent settlements by the SEC with international corporations have demonstrated the possibility of FCPA settlements in the hundreds of millions of dollars. Whistleblowers contemplating the new SEC whistleblower provisions of the Wall Street Reform Act will have a huge new financial incentive to come forward with allegations of wrongdoing, in both domestic markets and abroad.
See the final text of the bill at http://thomas.loc.gov/cgi-bin/query/R?r111:FLD001:H54978
News coverage is available at http://www.reuters.com/article/idUSTRE66K1QR20100722?feedType=RSS&feedName=topNews
Posted in Federal False Claims Act, State False Claims Acts | No Comments »
Thursday, July 22nd, 2010
Teva Pharmaceuticals, the Israeli generic pharmaceutical manufacturer, has settled, for $169 million, claims pending against it in Texas, California and Florida related to overpricing of its pharmaceutical products. Under the scheme, Teva had provided the drugs at issue to private pharmacies including Walgreens and Wal-Mart at steeply discounted rates, but reported higher prices to the states’ Medicaid programs. When Medicaid recipients were dispensed Teva products from the various pharmacies, the states reimbursed the pharmacies at higher rates than the pharmacies had actually paid, thus costing the taxpayers of those states significant unnecessary extra tax burden. Under the settlement, Teva does not admit liability. Texas will receive $51 million and Florida will receive $27 million. Additionally, the federal government and the State of California will divvy up the remaining $90 million contemplated by the settlement. Several other defendants remain as defendants to the lawsuits.
For more information, see the Texas Attorney General’s Press Release, available at http://www.oag.state.tx.us/oagNews/release.php?id=3413,
and the Florida Attorney General’s Press Release, available at http://www.myfloridalegal.com/newsrel.nsf/newsreleases/F45002F9757B9E478525776600519A18
Posted in Pharmaceuticals, State False Claims Acts | No Comments »
Thursday, July 22nd, 2010
Sodexo, the world’s largest private food purchaser, has agreed to settle claims that it overcharged New York state school districts and the State University of New York from 2004 until 2009. For $20 million, Sodexo will settle the claims of 21 public school districts and SUNY that Sodexo failed to pass along rebates it received from the suppliers of the food and equipment. Under the contracts with the various entities and under federal and state laws, Sodexo was required to acknowledge or pass on the rebates. The settlement is the largest under the New York State False Claims Act that does not involve Medicaid Funds.
For more information, see http://www.ag.ny.gov/media_center/2010/july/july21a_10.html
Posted in State False Claims Acts | No Comments »
Thursday, July 22nd, 2010
Elan Corporation, plc, of Dublin, Ireland has agreed to settle claims related to the marketing of Zonegran, an anti-epileptic drug for which it sold the rights to a Japanese company in 2004. In January of 2006, Elan admitted that the the DOJ and the Department of Health and Human Services were looking into its marketing practices, but has since declined to elaborate. The product was approved for use in the United States in 2000. Under the agreement, reached with the United States Attorney for the District of Massachusetts, Elan will resolve all federal and state-based claims for $203.5 million. Elan Pharmaceuticals, Inc., a U.S.-based subsidiary, will plead guilty to a misdemeanor.
For more information see http://www.forbes.com/feeds/ap/2010/07/15/business-health-care-us-elan-settlement_7771887.html?boxes=Homepagebusinessnews
Posted in Federal False Claims Act, Pharmaceuticals, State False Claims Acts | No Comments »
Friday, June 11th, 2010
The Florida Attorney General settled claims under the state’s false claims act against Office Depot for allegedly overcharging government offices for supplies. The case was settled for $4.5 million. As part of the settlement, the state of Florida will also be reimbursed an additional $1.3 million for its investigative and legal expenses.
The claims centered on allegations that Office Depot unilaterally and without notice switched pricing plans, resulting in higher prices to the government, as well as to unrelated non-profit organizations. David Sherwin, a former Office Depot account manager reported the overpricing scheme in May 2008.
More information can be found at: http://www.myfloridalegal.com/newsrel.nsf/newsreleases/370FC8DA33D527C9852577380060920D
Posted in State False Claims Acts | No Comments »
Monday, June 7th, 2010
The State of Idaho has agreed to settle claims against two groups of the Actavis pharmaceutical company related to allegations that Actavis knowingly inflated reported wholesale prices of certain drugs in order to receive extra compensation from the State’s Medicaid program. For $1.2 million, the two Actavis companies will be released from a lawsuit that was filed in 2007 by the State’s Attorney General against them and other pharmaceutical companies, including Astrazeneca, Merck, Johnson & Johnson and others. The drug companies’ scheme, according to the allegations of the suit, was to provide false information to the State regarding the cost of the drugs in order to increase the revenue from sale of the drugs through the program. The complaint also alleged that the drug companies used the extra margin created by the fraud to further market their drugs to consumers. Actavis does not admit liability and avoids being excluded from the State’s Medicaid program in the future as a result of the agreement, which must be approved by the Idaho State court.
See the Idaho Attorney General’s news release here: http://www2.state.id.us/ag/newsrel/2010/nr_may272010.htm
Posted in Healthcare, State False Claims Acts | No Comments »
|
|
|
|
|
|
 |
 |
|
|
 |
| |
215-320-6200 |
 |
© 2010 False Claims Act. All rights reserved. | |
 |
Attorney Advertising |
 |
The information on this site is not, nor is it intended to be, legal advice. Prior results do not guarantee a similar outcome. |
| |
|
|
 |
|
 |
|
 |